Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Pathways (CLPA) -- Ignore unavailable to you. Want to Upgrade?

To: Dr. Seuss who wrote (307)	10/28/1999 11:43:00 AM
From: StockMiser	Read Replies (1) \| Respond to of 566

Tsk tsk...let's not get into name calling. The information was presented as it was found. People can make their own judgements about what the actual trading float is. Seems like all you do is throw around assertions without any facts at all. Saying that "it all comes down to the FDA" is simply stating the obvious, and is characteristic of 100% of all development stage biotechs. Why exactly do you think the FDA won't approve the drug? I'm quite familiar with the FDA approval process, and in particular drug approvals relating to cancer therapies. Where exactly do you see a problem? Please enlighten me. SM